A Mayo Clinic study has suggested that the combination of biologic therapy with immune-suppressing drugs first instead of the drugs alone can be more than just beneficial to prompt remission from Crohn’s disease in a better way.
The study was published in the April 15, 2010 issue of the New England Journal of Medicine.
The study results are worthwhile enough to initiate a change in clinical practice, according to William Sandborn, M.D., gastroenterologist and vice chair of the Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester.
